Further studies are needed to improve the accuracy and sensitivity of allergen testing, including increased detection of the possible compounds of COVID-19 vaccines (such as tromethamine, EDTA, or spike protein), dosage adjustment, or increased additional cell markers (e.g., MRGPRX2). This evidence concerns the gene MRGPRX2 and COVID-19.